Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
31.77
+0.62 (1.99%)
At close: Apr 14, 2026, 4:00 PM EDT
31.71
-0.06 (-0.19%)
After-hours: Apr 14, 2026, 7:54 PM EDT
Teva Pharmaceutical Employees
Teva Pharmaceutical Industries had 33,950 employees as of December 31, 2025. The number of employees decreased by 2,880 or -7.82% compared to the previous year.
Employees
33,950
Change (1Y)
-2,880
Growth (1Y)
-7.82%
Revenue / Employee
$508,336
Profits / Employee
$41,532
Market Cap
36.99B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 33,950 | -2,880 | -7.82% |
| Dec 31, 2024 | 36,830 | -1,021 | -2.70% |
| Dec 31, 2023 | 37,851 | 1,025 | 2.78% |
| Dec 31, 2022 | 36,826 | -711 | -1.89% |
| Dec 31, 2021 | 37,537 | -2,679 | -6.66% |
| Dec 31, 2020 | 40,216 | 177 | 0.44% |
| Dec 31, 2019 | 40,039 | -2,496 | -5.87% |
| Dec 31, 2018 | 42,535 | -9,257 | -17.87% |
| Dec 31, 2017 | 51,792 | -5,168 | -9.07% |
| Dec 31, 2016 | 56,960 | 14,072 | 32.81% |
| Dec 31, 2015 | 42,888 | -121 | -0.28% |
| Dec 31, 2014 | 43,009 | -1,936 | -4.31% |
| Dec 31, 2013 | 44,945 | -1,003 | -2.18% |
| Dec 31, 2012 | 45,948 | 194 | 0.42% |
| Dec 31, 2011 | 45,754 | 6,094 | 15.37% |
| Dec 31, 2010 | 39,660 | 4,571 | 13.03% |
| Dec 31, 2009 | 35,089 | -3,218 | -8.40% |
| Dec 31, 2008 | 38,307 | 10,395 | 37.24% |
| Dec 31, 2007 | 27,912 | 1,242 | 4.66% |
| Dec 31, 2006 | 26,670 | 11,972 | 81.45% |
| Dec 31, 2005 | 14,698 | 885 | 6.41% |
| Dec 31, 2004 | 13,813 | 2,853 | 26.03% |
| Dec 31, 2003 | 10,960 | 1,383 | 14.44% |
| Dec 31, 2002 | 9,577 | 591 | 6.58% |
| Dec 31, 2001 | 8,986 | 361 | 4.19% |
| Dec 31, 2000 | 8,625 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,455 |
| Viatris | 30,000 |
| Dr. Reddy's Laboratories | 27,811 |
| Haleon | 24,535 |
| Zoetis | 14,500 |
| Elanco Animal Health | 9,900 |
| Alkermes | 2,050 |
| Neurocrine Biosciences | 2,000 |
TEVA News
- 12 hours ago - Community Routes: Access to Mental Health Care Provides Continued Funding for Mental Health Services at Free & Charitable Clinics - GlobeNewsWire
- 5 days ago - TEVA's Price Target Raised by B of A Securities, Maintains 'Buy' Rating | TEVA Stock News - GuruFocus
- 6 days ago - Teva Pharmaceutical Industries Ltd (TEVA) Trading 3.32% Higher on Apr 8 - GuruFocus
- 6 days ago - Notable ETF Inflow Detected - ACWX, SPOT, TEVA, SUNB - Nasdaq
- 14 days ago - Teva Pharmaceutical Industries Ltd (TEVA) Stock Price Up 2.86% on Mar 31 - GuruFocus
- 15 days ago - Teva (TEVA) Advances with Biosimilar Application Review for Xolair - GuruFocus
- 15 days ago - FDA Approves Teva's (TEVA) Ponlimsi as Prolia Biosimilar - GuruFocus
- 15 days ago - Teva Pharmaceutical Industries Ltd (TEVA) Shares Down 3.49% on Mar 30 - GuruFocus